Inhibikase Clinical Trial Eligibility Form

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

Inhibikase Clinical Trial Eligibility Form

This trial is testing a potential disease-modifying medication for early stage Parkinson's disease.
Multiple visits over the course of up to 12 weeks. Participants are randomly assigned to either active medication or a placebo pill. A spinal tap and skin biopsy are optional.

Sign in to Google to save your progress. Learn more

* Indicates required question

Are you between 30-75 years old and have a diagnosis of Parkinson's disease? *

Yes

No

Next

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy